Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Retained Earnings: 2012-2025

Historic Retained Earnings for Ptc Therapeutics (PTCT) over the last 13 years, with Sep 2025 value amounting to -$2.8 billion.

  • Ptc Therapeutics' Retained Earnings rose 20.99% to -$2.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.8 billion, marking a year-over-year increase of 20.99%. This contributed to the annual value of -$3.6 billion for FY2024, which is 11.06% down from last year.
  • As of Q3 2025, Ptc Therapeutics' Retained Earnings stood at -$2.8 billion, which was up 0.56% from -$2.8 billion recorded in Q2 2025.
  • Ptc Therapeutics' 5-year Retained Earnings high stood at -$1.7 billion for Q1 2021, and its period low was -$3.6 billion during Q4 2024.
  • In the last 3 years, Ptc Therapeutics' Retained Earnings had a median value of -$3.1 billion in 2023 and averaged -$3.2 billion.
  • Its Retained Earnings has fluctuated over the past 5 years, first crashed by 30.66% in 2022, then increased by 20.99% in 2025.
  • Ptc Therapeutics' Retained Earnings (Quarterly) stood at -$2.1 billion in 2021, then declined by 26.65% to -$2.7 billion in 2022, then decreased by 23.58% to -$3.3 billion in 2023, then declined by 11.06% to -$3.6 billion in 2024, then increased by 20.99% to -$2.8 billion in 2025.
  • Its last three reported values are -$2.8 billion in Q3 2025, -$2.8 billion for Q2 2025, and -$2.8 billion during Q1 2025.